Founded in 2010, Mercia Fund Management is a Henley-in-Arden, United Kingdom based venture capital firm. They look to invest in early-stage technology start-ups located in the West Midlands. Their initial investment is typically between £50,000 and £250,000 and they have the capacity to follow on with a limit of £1 million investment per company.
Mercia Fund Management manages £12.8 million funds under management raised from a mixture of public and private sector fund investors.
Mercia Fund Management has made investments in Invizius, GeckoLabs, PHARMASEAL, ClinSpec Diagnostics, BlackCurve, Quick Reach, Cyan Forensics, Notify Technology, Chromition, Tungl, Kumulos, ArcVehicle, Adapttech, Sugdens and Pertinax Pharma Ltd.
They exited their investments in PolyTherics, Pubguard and Allinea Software.
Timeline
Funded Companies
People
Abbie Barclay
Fund Administrator
Alice Grieve
Compliance Manager
Alison Dwyer
Head of Marketing & Communication, Senior Management Team
Alissia Dean
Investment Associate
Ceri Bailey
Group Financial Controller, Senior Management Team
Claire Anderson
EIS Client Services Associate
Clive Downward
Investment Director
David Baker
Investment Associate
Dr Alistair Forbes
Investment Director, Head of Software & the Internet
Dr Graham Davies
Investment Director
Dr Isabel Dodd
Investment Associate
Dr. Nicola Broughton
Investment Director, Head of Universities
Ella Cuthbert
Assistant Accountant
Emma Cross
Portfolio Associate
Hannah Barnao
Marketing Graphics and Even Coordinator
Hasan Ahmed
Data Scientist
Helen Birch
Office Administrator
Ian Atkinson
Investment Manager
James Allsop
Investment Manager
John Ellis
Portfolio Executive
Jonathan Craig
Investment Manager
Jonathan Diggines
Funds, Investment Committee Member /Chair
Julian Dennard
Fund Principal, Senior Management Team
Martin Glanfield
Chief Financial Officer
Maurice Disasi
Investment Associate
Venture capital firm
Company
Venture capital
United Kingdom
Henley-in-Arden
Mark Payton
ACELERON
Oxford Ionics
nanoTherics
